USP10 and colorectal carcinoma: Therefore, after treating CRC cells with oxaliplatin (7.5 μM) for 24 h, an IF assay was performed, and nuclear, cytoplasmic, and total proteins were extracted for western blot assay to determine whether oxaliplatin induces this change in USP10 by activating ATM kinase activity.